Internal Medicine · Monterey, CA
NPI
1891893657
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
5 Lower Ragsdale Dr Ste 100
Monterey, CA, 93940
Phone (831) 649-3375
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
2,091 services
Medicare patients, 2024
877
Average age 74
Drug cost, 2024
$1.8M
4,193 prescriptions
Company payments, 2025
$1,329
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Najwa Bahu Baugh was code 99214 (office e&m - established), 469 times for 408 patients. In total Najwa Bahu Baugh billed 2,091 services in 48 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 469 | 408 | $77.56 | $36K |
| 99213 Office E&M - Established | Office | 423 | 333 | $64.52 | $27K |
| 99204 Office E&M - New | Office | 105 | 105 | $133.27 | $14K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 99 | 99 | $137.89 | $14K |
| G0008 Administration of influenza virus vaccine | Office | 73 | 73 | $34.31 | $2,505 |
| 90662 Vaccine Product | Office | 71 | 71 | $80.67 | $5,727 |
| 94060 Pulmonary Function Testing | Office | 40 | 40 | $25.73 | $1,029 |
| 96372 Injection Administration | Office | 38 | 30 | $11.75 | $446 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 36 | 13 | $0.55 | $19.63 |
| 99203 Office E&M - New | Office | 34 | 34 | $87.23 | $2,966 |
| 81003 Clinical Chemistry | Office | 31 | 23 | $2.20 | $68.2 |
| 36415 Venipuncture Blood Collection | Office | 28 | 27 | $8.65 | $242 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 27 | 27 | $174.50 | $4,712 |
| J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Office | 21 | 21 | $0.08 | $1.68 |
| 90677 Vaccine Product | Office | 16 | 16 | $273.83 | $4,381 |
By year: 2022 $96K for 2,027 services; 2023 $112K for 1,694 services; 2024 $121K for 2,091 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 31 | 23 | $2.20 | $68.2 |
| 36415 Venipuncture Blood Collection | 28 | 27 | $8.65 | $242 |
| 83036 Blood Count | 16 | 16 | $9.52 | $152 |
Medicare prescription drug claims, 2024
In 2024, the drug Najwa Bahu Baugh prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 566 prescriptions and refills. In total Najwa Bahu Baugh wrote 4,193 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 566 | 759 | 140 | $481K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 519 | 572 | 238 | $15K |
| Montelukast Sodium Generic | 289 | 754 | 102 | $4,852 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 168 | 215 | 46 | $134K |
| Breo Ellipta Fluticasone/Vilanterol | 153 | 201 | 44 | $77K |
| Spiriva Respimat Tiotropium Bromide | 137 | 151 | 39 | $77K |
| Ventolin Hfa Albuterol Sulfate | 114 | 121 | 63 | $7,299 |
| Symbicort Budesonide/Formoterol Fumarate | 114 | 136 | 34 | $30K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 101 | 130 | 33 | $11K |
| Amoxicillin Generic | 101 | 125 | 22 | $186 |
| Azithromycin Generic | 93 | 93 | 63 | $385 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 75 | 83 | 17 | $37K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 74 | 106 | 24 | $7,480 |
| Prednisone Generic | 68 | 96 | 30 | $322 |
| Arnuity Ellipta Fluticasone Furoate | 68 | 77 | 16 | $15K |
Brand drugs: 2,170 claims; generic drugs: - claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Najwa Bahu Baugh $1,329 ($1,329 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $226.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $226 |
| Pfizer Inc. PFE | 9 | $169 |
| Actelion Pharmaceuticals US, Inc. JNJ | 8 | $164 |
| Merck Sharp & Dohme LLC MRK | 5 | $144 |
| GlaxoSmithKline, LLC. GSK | 5 | $98.37 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $64.89 |
| Lilly USA, LLC LLY | 3 | $63.58 |
| Novo Nordisk Inc NVO | 3 | $63.52 |
| Axsome Therapeutics, Inc. AXSM | 3 | $53.9 |
| Viatris Specialty LLC | 2 | $50.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.